Effects of Omalizumab Treatment on Some Biomarkers in Severe Allergic Asthma Patients


ONUR S. T., Yalcin A. D., GÜMÜŞLÜ S., Genc G. E., Kiraz K., ALTIN S.

EURASIAN JOURNAL OF PULMONOLOGY, vol.19, no.2, pp.84-90, 2017 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.5152/ejp.2017.64935
  • Journal Name: EURASIAN JOURNAL OF PULMONOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.84-90
  • Keywords: Asthma, biomarkers, omalizumab, ANTI-IGE, CYTOKINE PRODUCTION, HOMOCYSTEINE, EOSINOPHIL, IL-1-BETA, SCD200, CELLS
  • Akdeniz University Affiliated: Yes

Abstract

Objective: The mechanism of biological treatment molecule called omalizumab used in asthma treatment is thought to be versatile; however, the mechanism still remains unknown. This study was undertaken in severe asthma patients underwent omalizumab treatment, in order to investigate the relationship between biomarker expression and disease characteristics related to the immune system.